Company Profile
UBE Corporation, together with its subsidiaries, engages in the materials and machinery businesses in Japan, Asia, Europe, North America, and internationally. The company operates through Functional Products, High-Performance Urethanes, Pharmaceuticals, Resin and Chemical Products, Machinery, and Others segments. Its Functional Products segment offers polyimides, separation membranes, ceramics, and separators. The High-Performance Urethanes segment provides urethane resin intermediate, elastomers, and coating products. Its Pharmaceuticals segments engages in the drug discovery and the contract manufacturing and sales of pharmaceutical raw materials and intermediates. The Resin and Chemical Products segment provides composite, nylon polymer, caprolactam, ammonium sulfate, industrial chemicals, and elastomer. Its Machinery segment offers die casting machines, extrusion presses, injection molding machines, ceramics machinery, chemical equipment, crushers, transport machines, dust removers, as well as bridges, steel structures, etc. The Other segment is involved in electricity supply, real estate sales, leasing, and management, etc. The company was formerly known as Ube Industries, Ltd. UBE Corporation was founded in 1897 and is headquartered in Minato, Japan.
Latest News
Inseego Subscribe Achieves New CMMC Certification, Enabling Service Providers to Support U.S. Government Customers
Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
The Vanguard ETF Built for Long-Term Investors Who Want Reliable Results
Airspan Delivers Revenue Growth and Profitability in First Half 2026
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Website | https://www.ube.com |
| Audit Risk | 1 |
| Board Risk | 2 |
| Overall Risk | 2 |
| Market Cap | 323.10B |
| Trailing P/E | 13.53 |
| Forward P/E | 9.68 |
| Dividend Rate | 160 |
| Dividend Yield | 4.89% |
| Trailing Annual Div. Rate | 110 |
| Trailing Annual Div. Yield | 3.36% |
| Trailing EPS | 245.88 |
| Forward EPS | 343.42 |
| Book Value | 4,500.61 |
| Price-to-Book | 0.74 |
| Enterprise-to-Revenue | 1.38 |
| Enterprise-to-EBITDA | 13.75 |
| Ex-Dividend Date | 09/29/2026 |
| Earnings Date | 08/07/2026 |
| Earnings Call Date | |
| Revenue Average | 116.60B |
| Revenue Low | 112.00B |
| Revenue High | 121.20B |